Complex partial seizure causes memory loss with involvement of temporal lobe (
2). Patients with complex partial seizure have impaired cognitive and executive functions (
3). Our patient was complaining about memory loss and losing his important things. His long- term memory was mainly reduced but his short- term memory was also reduced. His responses about childhood history were delayed and not clear and at the same time he did not remember the time of neurologist’s visit. It seemed that his memory loss was affected by his mild depression, at least partially, but his long- term memory loss might be associated with hippocampus atrophy (
4).
Tramadol is an analgesic agent with dual mechanism. It is agonist of μ opioid receptors and inhibits reuptake of serotonin and norepinephrine (
5). Generalized seizure is a known non-dose- dependent side effect of tramadol (
6). Our patient had seizure after starting tramadol, 300 mg per day. At this stage, he had no aura, however, aura was present when the dose of tramadol was increased to 2000 mg per day. It seemed that generalized seizures were converted to complex partial ones by involvement of hippocampus, but the conversion is under question with unreliable patient’s memory.
Notable atrophy of hippocampus in various MRI cuts with widening of Sylvian fissure, distention of the left lateral ventricle, and loss of normal architecture of hippocampus in the left side were suggesting mesial temporal sclerosis (MTS), the most common cause of drug resistant epilepsy (
7). Main causes of MTS are traumatic brain injury, inflammatory process, eg, infections and recurrent seizure. To explain the possible association between tramadol and hippocampus atrophy, previously recurrent or prolonged seizures have been attributed to mesial temporal sclerosis (
8). Tramadol is associated with lower threshold and higher rate of seizure (
9). Another explanation is that there are evidences about association of tramadol with disorganization of neurons, apoptosis, chromatin changes, blurred nucleolus, intercellular edema, and capillary congestion in brain tissues. Tramadol also increases oxidative stress and cell damages with decreased non- enzymatic anti- oxidative activity, reduced glutathione peroxidase activity, altered glucose metabolism, and suppressed insulin signaling (
10-
12).
There were no data on existence of MTS before tramadol abuse. Absence of previous traumatic or inflammatory process or seizure and atrophy, without prominent hyper signal lesion in MRI, were all suggesting that hippocampus atrophy was a recent event.
In conclusion, hippocampus atrophy may be associated with tramadol abuse. The present case is preliminary evidence about association of tramadol with complex partial seizure. Considering an increasing abuse of tramadol, conducting further studies is highly recommended.